sFlt-1/PlGF ratio as a predictive and prognostic marker for preeclampsia
| Autor: | Eun Young Woo, Hae Rin Jeon, Da Hoe Jeong, Gwi Taek Shin, Suk-Young Kim, Jin Young Lee |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Placental growth factor
medicine.medical_specialty Neonatal intensive care unit Sflt 1 plgf ratio Preeclampsia 03 medical and health sciences 0302 clinical medicine Pre-Eclampsia Predictive Value of Tests Pregnancy medicine Humans Neonatal weight reproductive and urinary physiology Placenta Growth Factor 030219 obstetrics & reproductive medicine Vascular Endothelial Growth Factor Receptor-1 business.industry Obstetrics Infant Newborn Obstetrics and Gynecology Membrane Proteins medicine.disease Prognosis 030220 oncology & carcinogenesis embryonic structures Female medicine.symptom business Weight gain Body mass index Biomarkers |
| Zdroj: | The journal of obstetrics and gynaecology researchReferences. 47(7) |
| ISSN: | 1447-0756 |
| Popis: | OBJECTIVE Preeclampsia is clinically unpredictable and associated with adverse outcomes. Pregnant women with suspected preeclampsia require intensive monitoring or hospitalization for elevated sFlt-1 (soluble fms-like tyrosine kinase-1) to PlGF (placental growth factor) ratios before symptoms arise. We aimed to determine the sFlt-1/PlGF ratio's usefulness in predicting adverse pregnancy outcomes in preeclampsia. METHODS From January 2017 to February 2019, we measured the sFlt-1/PlGF ratio in 73 singleton pregnant women suspected of preeclampsia and classified them into three groups: low-risk (sFlt-1/PlGF ratio |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text